A plasma SNORD33 signature predicts platinum benefit in metastatic triple-negative breast cancer patients.

ABSTRACT:

SUBMITTER: Wang B 

PROVIDER: S-EPMC8764855 | biostudies-literature | 2022 Jan

REPOSITORIES: biostudies-literature